The effects of Delta(12)-PGJ(2) on malignant cells.
Mc Clay
E F
EF
Department of Medicine, Division of Hematology/Oncology, and the Cancer Center, University of California, La Jolla, USA.
D000818:Animals; D006801:Humans; D015230:Prostaglandin D2 / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000031:analogs & derivatives; D014407:Tumor Cells, Cultured
C040810:9-deoxy-9,10-didehydro-12,13-didehydro-13,14-dihydroprostaglandin D2; D015230:Prostaglandin D2